{"database": "openregs", "table": "documents", "rows": [["FDA-2006-N-0483-0001", "FDA", "FDA-2006-N-0483", "International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization Scheduling Recommendations for Dronabinol and its Stereolsomers, and Oripavine", "Notice", "General Notice", "2006-12-15T05:00:00Z", 2006, 12, "2006-12-14T05:00:00Z", "2007-01-17T04:59:59Z", "2025-07-09T00:08:54Z", "E6-21318", 0, 0, "0900006480463157"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2006-N-0483-0001"], "units": {}, "query_ms": 0.6159100448712707, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}